Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes ...
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunot
Vertex Pharmaceuticals is proud to work with organizations that help the type 1 diabetes community live active, full lives.
Type 1 DiabetesOptimal ControlPontryagin’s Maximum Principle\n\nGlucoseInsulinDiabetes mellitus is a metabolic disease characterized by elevated concentrations of bloodglucose for prolonged periods of time, which is a result of insufficient endocrine of insulinfrom 尾 -cells of pancreas or inefficient ...
Diabetes is a major disease that threatens human health -- with type 1 diabetes being one of the more severe forms. It is difficult to achieve precise blood sugar control through current treatment methods, leading to various complications that severely affect patients' quality of life. ...
Type 1 diabetes affects millions of people globally and requires careful management to avoid serious long-term complications, including heart and kidney disease, stroke, and loss of sight. The type 1 diabetes patient cohort is highly heterogeneous, with
Over the past decade, there had been progress in the development of cell therapy for insulin-dependent diabetes. Nevertheless, important hurdles that need to be overcome still remain. Protocols for the differentiation of pluripotent stem cells into pancr
A cure for type 1 diabetes (T1D) would help millions of people worldwide but remains elusive to date. Tolerogenic vaccines and β-cell replacement therapy are complementary therapies that seek to address aberrant T1D autoimmune attack and subsequent β-cell loss. However, both approaches require ...
Type 1 diabetes is an autoimmune disease that causes loss of pancreatic beta cells, which produce endogenous insulin. To replace that, patients must take exogenous insulin by shots or pump and are at risk of dangerous low blood sugar events. There is no current oral treatment for this d...
type 1 diabetes. Lantidra is approved for the treatment of adults with type 1 diabetes who are unable to approach target glycated hemoglobin (average blood glucose levels) because of current repeated episodes of severe hypoglycemia (low blood sugar) despite intensive diabetes manag...